Ligand Pharmaceuticals, Inc. (LGND)
284.27
+0.17
(+0.06%)
USD |
NASDAQ |
Sep 01, 16:00
284.33
+0.06
(+0.02%)
After-Hours: 20:00
Ligand Pharmaceuticals Cash from Operations (Annual) : 49.36M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 49.36M |
| December 31, 2024 | 96.62M |
| December 31, 2023 | 48.63M |
| December 31, 2022 | 137.85M |
| December 31, 2021 | 78.80M |
| December 31, 2020 | 54.59M |
| December 31, 2019 | -29.34M |
| December 31, 2018 | 194.06M |
| December 31, 2017 | 93.57M |
| December 31, 2016 | 63.00M |
| December 31, 2015 | 40.47M |
| December 31, 2014 | 20.57M |
| December 31, 2013 | 20.69M |
| December 31, 2012 | 0.161M |
| December 31, 2011 | -1.172M |
| December 31, 2010 | -27.07M |
| December 31, 2009 | -33.80M |
| Date | Value |
|---|---|
| December 31, 2008 | -20.62M |
| December 31, 2007 | -97.73M |
| December 31, 2006 | -138.52M |
| December 31, 2005 | 8.365M |
| December 31, 2004 | 5.754M |
| December 31, 2003 | 0.274M |
| December 31, 2002 | -25.11M |
| December 31, 2001 | -19.91M |
| December 31, 2000 | -47.36M |
| December 31, 1999 | -60.54M |
| December 31, 1998 | -66.65M |
| December 31, 1997 | -13.36M |
| December 31, 1996 | -33.30M |
| December 31, 1995 | -37.87M |
| December 31, 1994 | -14.31M |
| December 31, 1993 | -10.61M |
| December 31, 1992 | -10.49M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |
| Zevra Therapeutics, Inc. | -1.598M |
| Liquidia Corp. | -35.69M |